[1] World Health Organization. Guidelines for prevention,care and treatment of persons with chronic hepatitis B infection[R]. Geneva:WHO,2015.
|
[2] An Advisory Committee Statement(ACS)National Advisory Committee on Immunization(NACI). Update on the recommended use of Hepatitis B vaccine[R]. ACS,2015.
|
[3] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[4] World Health Organization. Hepatitis B vaccines:WHO position paper-July 2017[J]. Wkly Epidemiol Rec,2017,92(27):369-392.
|
[5] TERRAULT NA,LOK ASF,McMAHON BJ,et al. Update on prevention,diagnosis,and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology,2018,67(4):1560-1599.
|
[6] WANG FS,FAN JG,ZHANG Z,et al. The global burden of liver disease:The major impact of China[J]. Hepatology,2014,60(6):2099-2108.
|
[7] CUI F,SHEN L,LI L,et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy,China[J].Emerg Infect Dis,2017,23(5):765-772.
|
[8] Chinese Center for Disease Control and Prevention. Prevention and control of infectious diseases[EB/OL]. http://www. nhc.gov. cn/jkj/s3578/201904/050427ff32704a5db64f4ae1f6d57c6c.shtml.(in Chinese)中国疾病控制中心.传染病预防控制[EB/OL]. http://www. nhc.gov. cn/jkj/s3578/201904/050427ff32704a5db64f4ae1f6d57c6c. shtml.
|
[9] TEO EK,LOK ASF. Hepatitis B virus immunization in adults[EB/OL].[2019-06-13]. https://www. uptodate. com/contents/hepatitis-b-virus-immunization-in-adults?search=%E4%B9%99%E8%82%9D%E7%96%AB%E8%8B%97&source=Out%20of%20date%20-%20zhHans&selectedTitle=3~150.
|
[10] Bureau of Disease Prevention and Control. Immunization procedure of vaccines in National Immunization Program for children and related explanations(version 2016)[EB/OL].[2016-12-6]. http://www. nhc. gov. cn/ewebeditor/uploadfile/2016/12/20161229154305808. docx.(in Chinese)疾病预防控制局.国家免疫规划疫苗儿童免疫程序及说明(2016年版)[EB/OL].[2016-12-6]. http://www. nhc. gov. cn/ewebeditor/uploadfile/2016/12/20161229154305808. docx.
|
[11] DIAO LD,SUN XD. Pratical vaccinology[M]. Shanghai:Shanghai Scientific&Technical Publishers,2015:226-242.(in Chinese)刁连东,孙晓东.实用疫苗学[M].上海:上海科技出版社,2015:226-242.
|
[12] KUHNS MC,McNAMARA AL,HOLZMAYER V,et al. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors[J]. Virol J,2019,16(1):43.
|
[13] QIN Y,LIAO P. Hepatitis B virus vaccine breakthrough infection:Surveillance of S gene mutants of HBV[J]. Acta Virol,2018,62(2):115-121.
|
[14] SCHILLIE S,MURPHY TV,FENLON N,et al. Update:Shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers[J]. MMWR Morb Mortal Wkly Rep,2015,64(39):1118-1120.
|
[15] ZHU Q,YU G,YU H,et al. A randomized control trial on interruption of HBV transmission in uterus[J]. Chin Med J(Engl),2003,116(5):685-687.
|
[16] ZHU QR. Vaccination with hepatitis B vaccines should be taken seriously[J]. Chin J Pediatr,2014,52(8):561-562.(in Chinese)朱启镕.高度重视乙型肝炎疫苗的接种[J].中华儿科杂志,2014,52(8):561-562.
|
[17] Chinese Journal of Hepatology,Journal of Clinical Hepatology,and Chinese Hepatology. Several issues regarding prevention of mother-to-child transmission of hepatitis B virus[J]. J Clin Hepatol,2016,32(12):2227-2230.(in Chinese)中华肝脏病杂志,临床肝胆病杂志,《肝脏》杂志.预防HBV母婴传播中值得注意的几个问题[J].临床肝胆病杂志,2016,32(12):2227-2230.
|